enGene Therapeutics Inc. (ENGN) › Shares OutstandingenGene Therapeutics Inc. (ENGN) — Shares OutstandingAnnual figures by period end, from SEC filings.2022-10-31: 665.8K2023-10-31: 23.20M2024-10-31: 50.98M2025-10-31: 52.02M52.02M2022-10-31Shares Outstanding (shares)2025-10-31Period endedShares OutstandingChange YoYSource filing2025-10-3152.02M+2.0%2025-12-22Balance as of period end2024-10-3150.98M+119.7%2025-12-22Balance as of period end2023-10-3123.20M+3384.4%2024-12-19Balance as of period end2022-10-31665.8K—2024-01-29Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)